5681. The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.5682. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
作者: Emma K Accorsi.;Amadea Britton.;Katherine E Fleming-Dutra.;Zachary R Smith.;Nong Shang.;Gordana Derado.;Joseph Miller.;Stephanie J Schrag.;Jennifer R Verani.
来源: JAMA. 2022年327卷7期639-651页
Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.
5684. Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
作者: Lindsey Wang.;Pamela B Davis.;David C Kaelber.;Nora D Volkow.;Rong Xu.
来源: JAMA. 2022年327卷7期678-680页
This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.
|